Screener
Organogenesis Holdings Inc. ORGO Product — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Net product revenue | $42,805 | $100,779 | $79,055 | $187,472 |
| Grant income | 950 | 226 | 1,928 | 226 |
| Total revenue | 43,755 | 101,005 | 80,983 | 187,698 |
| Operating expenses: | ||||
| Cost of goods sold | 23,673 | 27,630 | 49,445 | 51,353 |
| Selling, general and administrative | 53,965 | 73,810 | 119,151 | 146,319 |
| Research and development | 18,297 | 10,395 | 33,458 | 21,035 |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s product — revenue?
- Organogenesis Holdings Inc. (ORGO) reported product — revenue of $42.81M in Q2 2026.
- How has Organogenesis Holdings Inc.'s product — revenue changed year-over-year?
- Organogenesis Holdings Inc.'s product — revenue decreased by 57.5% year-over-year, from $100.78M to $42.81M.
- What is the long-term trend for Organogenesis Holdings Inc.'s product — revenue?
- Over 2 years (2023 to 2025), Organogenesis Holdings Inc.'s product — revenue has grown at a 14.0% compound annual growth rate (CAGR), from $433.14M to $563.03M.
- What does product — revenue mean?
- This metric represents the total gross sales generated from the company's core regenerative medicine product portfolio, including advanced wound care and surgical and sports medicine solutions. It serves as a primary indicator of market adoption and commercial success for the company's proprietary medical technologies. Tracking this revenue stream provides insight into the company's ability to scale its core product offerings within the healthcare sector.
Ask your AI about Organogenesis Holdings Inc.'s product — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude